Keeping Track: CDER Novel Approvals Reach 11 With Corlanor In Busy Week For CV Drugs
Executive Summary
Weekly column reviews the latest drug development news from our FDA Performance Tracker. This week: updates on Amgen's Corlanor, ARCA biopharma's Gencaro and Aeterna Zentaris' Macrilen